Response to letter: "Does Ivabradine really limit dobutamine-induced tachycardia in stable heart failure patients: parallax in significance"

Int J Cardiol. 2015 Jan 20:179:217. doi: 10.1016/j.ijcard.2014.11.069. Epub 2014 Nov 6.

Authors

Romain Gallet¹, Julien Ternacle², Pascal Lim²

Affiliations

¹ APHP-Henri Mondor University Hospital, Cardiovascular Department, Team 3, Creteil, France; INSERM U955, Team 3, Creteil, France. Electronic address: [email protected].
² APHP-Henri Mondor University Hospital, Cardiovascular Department, Team 3, Creteil, France; INSERM U955, Team 3, Creteil, France.

PMID: 25464449
DOI: 10.1016/j.ijcard.2014.11.069

No abstract available

Keywords: Cardiogenic shock; Dobutamine; Heart failure; Ivabradine.

Publication types

Letter
Comment

MeSH terms

Benzazepines / administration & dosage*
Dobutamine / administration & dosage*
Female
Heart Failure, Systolic / diagnosis*
Heart Failure, Systolic / drug therapy*
Hemodynamics / drug effects*
Humans
Male
Severity of Illness Index*

Substances

Benzazepines
Dobutamine